Related Experiment Video
Updated: Apr 25, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[The prevalence and clinical significance of arthritis in patients with systemic sclerosis]
Chanyuan Wu1, Qian Wang1, Dong Xu1
1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100032, China.
Objective:
To explore the prevalence and independent influencing factors of arthritis in Chinese patients with systemic sclerosis (SSc).
Methods:
A total of 248 SSc patients were enrolled in this prospective cross-sectional study in Peking Union Medical College Hospital. Demographic, clinical and laboratory data were compared in arthritis group and non-arthritis group.
Results:
Of 248 Chinese SSc patients, mean age of onset was (37.1 ± 13.7) years old and disease duration was (7.4 ± 5.2) years. Overall prevalence of arthritis was 41.1% (102/248). The presence of arthralgia(95.1% vs 15.1%), muscle weakness (38.2% vs 24.7%), short of breath (60.8% vs 45.2%), and intestinal lung disease (64.7% vs 49.3%) occurred more frequently in patients with arthritis than those without arthritis (P < 0.05). The elevation of C reactive protein, anti-Sm and anti-cyclic citrullinated peptide were more common in arthritis group than in non-arthritis group (61.4% vs 43.9%, 11.4% vs 2.5% and 28.1% vs 2/16, respectively). There were no obvious differences in the Rodnan score, digital ulcers, pulmonary arterial hypertension, and six-minute walk test between two groups (P > 0.05).
Conclusion:
This study reveals the significant prevalence of arthritis in a large cohort of SSc patients in China. Compared to non-arthritis patients, the SSc patients with arthritis have a more severe inflammation reaction and a higher rate of intestinal lung disease.
More Related Videos
02:28Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction
Multiple Sclerosis l: Introduction